Yet the 10 percent decline in Atherton wasnt as severe as in Woodside and Hillsborough, two other affluent enclaves in the county where sales volume plummeted by more than half during that time, the data show. He discovered that low cost CMOSimage sensorscoupled to light-emitting DNA sequencing reactions could form the basis for building a less expensive, portable DNA sequencer. On September 18, 2020, Eltoukhy, Carson filed a Divorce,Separation - (Family) case against Eltoukhy, Helmy in the jurisdiction of San Mateo County, CA. Court documents are not available online for Family cases in California. At Guardant Health, we believe a simple blood test that can transform cancer care across the continuum is one of the most important world-changing ideas we have. Here are further demographic highlights of the leadership team: The Guardant Health executive team is 41% female and 59% male. At Illumina, Helmy was Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. He joined the Stanford Genome Technology Center, or SGTC, as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. For example, even though colonoscopy, the standard screening modality for colon cancer, is effective, it is invasive, costly, and complicated so screening rates, while having improved, still remain low overall. Public records show the home sold for $31.15 million in September 2021, just $150,000 more than the Warriors star bought it for in June 2019. [8] After successfully selling Trimedia to Xidex Corp. in February 1986[9], he worked for Xidex as VP for Research and Development for a few years before he was hired by Nashua Corp to revive their disk storage business. ; Additional Info: Original Type Family Law Status Conference Judicial Officer Padilla Jr., Rosendo Hearing Time 1:30 PM Result Not Held, Financial info for ELTOUKHY, CARSON; eFile Online Payment Receipt # 2020-036673-HOJ ELTOUKHY, CARSON $435.00, Financial info for ELTOUKHY, CARSON; Transaction Assessment $435.00, Financial; ELTOUKHY, CARSON; Total Financial Assessment $515.00; Total Payments and Credits $515.00, Cause Of Action. case Its solutions include treatment selection, recurrence detection, and early detection. Helmy is an entrepreneur and pioneer in the biotech industry. Whats happened in the last decade has really been the tipping point. Were starting with early-stage colorectal cancer (CRC), the second leading cause of death in the U.S. and a disease where an estimated 1030% of early-stage patients recur within five years. Eltoukhy, Helmy, We try to imagine all patients as our own family members. Helmy Eltoukhy received a doctorate, a graduate degree and an undergraduate degree from Stanford University. This case was filed in San Mateo County Superior Courts, Southern Branch Hall of Justice and Records located in San Mateo, California. Guardant Health can also be reached via phone at (855) 698-8887 and via email at [emailprotected] Learn More on Helmy Eltoukhy's contact information. Helmy Eltoukhy in 2013 left the genetic sequencing giant Illumina to cofound Guardant Health. Until fairly recently, until we came to launch Guardant360, off-the-shelf DNA sequencing technologies were not only unaffordable but not sensitive enough to see these trace fragments of DNA in a tube of blood. sputter induced micro-texturing enhancement for magnetic head structures. Market research is often dominated by early adopters, which can lead to complex products that dont resonate with 80% of users. How do you think this will change the world? One of the first patients we tested was a mother of two in her mid 40s who was diagnosed with late-stage pancreatic cancer and given a poor prognosis with only two months to live. This is the world-changing idea that we at Guardant Health have passionately pursued since I cofounded the company with AmirAli Talasaz over 8 years ago, and one that in 2021 is closer than ever to becoming reality. Executive Summary. Service Date: 02/1/2022, DocketClerk's Notice of Hearing. Weve taken a methodical approach to this vision of transforming cancer care across the continuum, including a blood test for the early detection of cancer. This net worth approximation does not reflect any other investments that Dr. Eltoukhy may own. Now our Guardant360 CDx is the first FDA-approved comprehensive liquid biopsy for any solid tumor cancer, so in many ways that represents another tipping point in helping to increase adoption of this technology. Can you tell us about your Big Idea That Might Change The World? Petition for Dissolution of Marriage/Domestic Partnership. More than 99% of his 2020 pay package is made up of equity awards that depend on Guardant's stock . 2018-10-09, San Mateo County Superior Courts | Family | As one of the early innovators in digital storage media, Eltoukhy was selected in 2006 as a member of the Oral History Panel on Hard Drive Transition to Thin Film Media, which was sponsored by the Computer History Museum in Mountain View, California. Once you do that, you need to make sure payers will cover the test. From left: Beth Seidenberg, Vijay Pande and Annie Lamont. Biography of Helmy Eltoukhy Founder of Guardant Health, Inc. and Avantome, Inc., Helmy Eltoukhy currently is Chief Executive Officer & Director at Guardant Health, Inc. Guardant's founders Eltoukhy and Talasaz want to remake cancer screening with their "liquid biopsy" technology, which can sniff out DNA fragments in the blood that indicate cancer-related biological markers. Growth of SingleCrystal Metastable Semiconducting (GaSb)1xGex Films. ; Additional Info: Comment Uniform Child Custody Jurisdiction & Enforcement Act. Liquid biopsy firms Personal Genome Diagnostics (PGDx) and Foundation Medicine are each being sued by Guardant for patent infringement. In 1980, he was appointed assistant professor of Materials Science and Electrical Engineering at the University of Southern California in Los Angeles, CA, where he continued his research on semiconductor superlattice structures using molecular beam epitaxy. By Emma Bardin. Related Topics: News, Cancer Care, Oncology, Science, Healthcare Comment Show comments What do you need to lead this idea to widespread adoption? Prior to founding our company, Dr. Eltoukhy held various positions at Illumina, Inc. from August 2008 to December 2012, including Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. Helmy studiedelectrical engineeringatStanford University, completing an acceleratedBachelor of Science (BS)in two years, followed byMaster of Science (MS)andDoctorate (PhD)degrees. You know, the vision is not even fighting cancer but if anybody has these genetic markers and so on, even detecting precursors to disease itself, quantitatively in the blood, Eltoukhy says. Helmy Eltoukhy is an American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection. And unlike those two submarkets, Atherton reported an average sales price increase from September to October, sitting at $10.6 million at the end of last month, MLSListings data show. As Fentanyl Deaths In Youth Rise, Will Digital Health Solutions Find Quicker Adaptation? Fred Swaniker, co-founder of African Leadership Academy, CEO and co-founder of African Leadership University. Early adopters are different than the bulk of eventual users and they care about different aspects of the product, even in healthcare. All rights reserved 2023 The Real Deal is a registered Trademark of Korangy Publishing Inc. Black U.K. Women Nearly Four Times More Likely To Die From Childbirth, 13-Year-Old Ohio Boy Dies After Trying The TikTok Benadryl Challenge, Contrary To Conventional Wisdom, Some Virusoids Do Produce Proteins. Helmy Eltoukhy is 41, he's been the Chief Executive Officer and Director of Guardant Health Inc since 2013. Its second was helping cancer patients, not through a blood test but by sequencing the genetic material from tumor biopsies in order to pick medicines for patients whose disease had spread and resisted standard treatmentsa market pioneered by Foundation Medicine, which is now part of Roche. In addition, he makes $914,906 as Chief Executive Officer and Director at Guardant Health Inc. Helmy has made over 24 trades of the Guardant Health Inc stock since 2019, according to the Form 4 filled with the SEC. Intellectual humility is a good thing. Terms & Conditions. I had lost my dearest friends and family to cancer, Talasaz says. Now in 2021, we are bringing our vision to fruition with earlier stage cancer. He published a number of scientific papers on semiconductor materials as well as on magnetic thin film alloys and deposition technology, including: He has also authored a large number of patents, including: Upon selling his first company, Trimedia to Xidex in a stock transaction, Eltoukhy started to study stock market volatility utilizing his background in math and statistics, thereby developing quantitative trading algorithms for equities and derivatives in 1986. He has focused on researching DNA sequencing to help lower cancer mortality rates. Get notified the next time Helmy Eltoukhy buys or sells Guardant Health stock. One success mindset that I think is important is intellectual humility. As CEO of the company, he helped raise more than $2.5 billion in funding for the company and took it public in October 2018. and B.S. Helmy's doctoralthesis, An integrated system for de novo DNA sequencing combinedgenomicsandsensor engineering. How can our readers follow you on social media? For four years, he worked as an executive in the companys research labs. The estimated Net Worth of Helmy Eltoukhy is at least $476 Million dollars as of 14 March 2023. ; Additional Info: Comment Final Declaration of Disclosure and Income & Expense Declaration filed. You have the added complexities of proving the clinical utility of your test to improve healthcare outcomes. Transaction Summary of Helmy Eltoukhy Guardant Health was founded to pioneer non-invasive liquid biopsy approaches for cancer diagnosis, monitoring, personalized medicine treatment, and research. Eltoukhy's career as a scientist/high tech entrepreneur culminated in the successful initial public offering of Stormedia in 1995.[11]. Atef Eltoukhy (born February 3,1951) is known for pioneering digital disk storage technology while working as a scientist and entrepreneur in early-1980s Silicon Valley. San Mateo County You can see the complete history of Mr. Eltoukhy stock trades at the bottom of the page. Richard Wall Lyman, former provost of Stanford University. The U.S. Preventive Services Task Force recommends all adults over 50 get screened for colon cancer, but currently only 69% of adults comply with these guidelines. Enter your email address below to get our daily insider buying and selling report. Likewise, the Eltoukhy Family Foundation funded endowed fellowships for the benefit of Egyptian/Middle Eastern students at the International House at UC Berkeley.[32]. A simple blood test can help improve these rates. Helmy Eltoukhy with Carson Eltoukhy Helmy Eltoukhy, Carson Eltoukhy prints Downloads Select Material: 4x6 $15.00 5x7 $20.00 8x10 $30.00 8x12 $30.00 8xWallet $17.95 Add to cart SHARE Choose if you want to purchase a print or a digital download of this photo Choose what type of print material you would like Helmy is passionate about healthcare and impact, and serves on the Cancer Leadership Council of UCSF Cancer Center. This chart shows Helmy Eltoukhy's buying and selling at Guardant Health by year and by quarter. DocketPetition for Dissolution of Marriage/Domestic Partnership. He became a scientist at the IBM Research Division in San Jose, where he used his research expertise in thin film deposition technology to investigate novel alloys and structures of various magnetic materials. Eltoukhys first company, Avantome, was acquired by Illumina for $60 million in 2008, one year after it was founded. Under Eltoukhys direction as CEO, Guardant Health raised over one billion dollars in financing, launched three products, established collaborations with oncology researchers, and gained recognition as a healthcare innovator inliquid biopsyapproaches used for cancer diagnosis and research. Which principles or philosophies have guided your life? These novel quant models launched a whole new career for Eltoukhy in money management without any prior education or training. Dr. Eltoukhy earned a salary of $1.00, and other compensation of $13,664.00. The corporate mailing address for Dr. Eltoukhy and other Guardant Health executives is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. For diagnostics, including a blood test that detects cancer early, the reality is you need all of these things to show the necessary healthcare benefit and achieve widespread adoption. Liquid biopsy firms Personal Genome Diagnostics (PGDx) and Foundation Medicine are each being sued by Guardant for patent infringement. Bits of cancer DNA can be found in a . Last updated: 16 March 2023 at 5:30pm EST. Since then, Guardant Healths liquid biopsy tests have been used by over 9,000 oncologists in over 150,000 samples to date. As a part of my series about Big Ideas That Might Change The World In The Next Few Years I had the pleasure of interviewing Helmy Eltoukhy. These 11 VC investors are behind some of the hottest deals. This case was filed in San Mateo County Superior Courts, with Greenberg, Susan presiding. As Health Plans Address Social Determinants, UnitedHealth Group To Make 2.5 Million Home Visits This Year, Englands Nurses To Strike Again After Rejecting Pay Deal. What if a simple blood test could detect cancer across all stages of the disease, even earliest when it can be treated most effectively? Skeptics worry that none of them will be able to work without accidentally diagnosing healthy people with cancers that do not need to be treated. Most recently, on Wednesday, March 15th, Helmy Eltoukhy bought 8,600 shares of Guardant Health stock. flash chromium interlayer for improved hard disk magnetic recording performance, a method for texturing a disc substrate, and a particle slurry for use in the method. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Palo Alto, CA. methods for texturing a magnetic disc substrate. BY Lucy Brewster. Helmy Eltoukhy - Guardant Health Co-Founder and CEO A San Francisco, California-based entrepreneur and scientist, Helmy Eltoukhy earned a bachelor of science in electrical engineering in less than three years at Stanford University, then went on to earn a master's degree in the same subject. The study showed that in 750 patients for whom mutations known to predict whether anti-cancer drugs were effective and a tumor biopsy was available, the blood test and biopsy matched more than nine times out of ten. The estimated net worth of Helmy Eltoukhy is at least $51.23 million as of March 15th, 2023. [There was] a lot of great progress on the research side, but not a lot of it was moving the needle on the clinical side., Talasaz had studied electrical engineering in Tehran. . A tenth of this DNA in a pregnant womans blood comes from her infant, Eltoukhy says. This is a civil action for correction of inventorship under the patent laws of the Like 'the size of a 747' or 'the length of a . And the best part of all, documents in their CrowdSourced Library are FREE! His PhD thesis explored new techniques for investigating the Crystal Growth and Electrical Properties of Sputtered Indium Gallium-Antimonide Thin Films.[6]. On average, Guardant Health Inc executives and independent directors trade stock every 7 days with the average trade being worth of $4,010,525. Linda Darling-Hammond, education advisor to Barack Obama's presidential campaign. Guardant Health CEO Helmy Eltoukhy and CNBC's Meg Tirrell discuss new cancer detecting advancements with CNBC's "Power Lunch" team. I believe this is why I was drawn to the application of electrical engineering tools to elucidate biology and potentially improve human health. The co-founder of startups Avantome and Guardant Health, Eltoukhy was named to Time Magazines inaugural 50 Most Influential People in Healthcare (2018) and Fortunes 40 under 40 (2017). The researchers claimed the blood test revealed a possible approved treatment option for 16% of patients and an experimental one for 72% of patients. The most recent stock trade was executed by John G. Saia on 15 April 2023, trading 7,568 units of GH stock currently worth $189,200. [28], The Eltoukhy family's philanthropic initiatives are focused on education in the U.S. and Egypt and are funded and managed by the Eltoukhy Family Foundation[29]. Superior Courts The dynamic duo of Helmy and AmirAli believes that the key to conquering cancer is to expand efforts to detect the cancers most likely to be cured through early intervention and access to their molecular information throughout all stages of the disease. Helmy Eltoukhy, Ph.D. is the co-founder of Guardant Health and has served as the companys Chief Executive Officer since January 2013. Discover the immediate steps you need to take now. 2020-10-22, Santa Clara County Superior Courts | Family | Learn More on Helmy Eltoukhy's contact information. The two researchers met as graduate students at Stanford in 2002 and then worked together at Illumina, the $40 billion (market cap) maker of DNA sequencing gear. Helmy Eltoukhy is an American scientist, entrepreneur, and investor best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. Couldnt a similar technology detect cancer, they wondered? What are your 5 Things I Wish Someone Told Me Before I Started and why. What Guardant plans is a methodical move from the sickest patients to those who do not yet have cancer. Greenberg, Susan presiding I believe this is why I was drawn to the application of Electrical tools... 'S Notice of Hearing, was acquired by Illumina for $ 60 million in 2008, one year after was... Complexities of proving the clinical utility of your test to improve healthcare outcomes as. Health stock ) 1xGex Films. [ 6 ] Eltoukhy may own research labs helmy is an American scientist entrepreneur!, a graduate degree and an undergraduate degree from Stanford University Eltoukhy and compensation... 505 PENOBSCOT Dr., REDWOOD CITY CA, 94063 about your Big Idea that Might change the world and... Adopters, which can lead to complex products that dont resonate with %... A tenth of this DNA in a with earlier stage cancer yet have.! With Greenberg, Susan presiding lower cancer mortality rates $ 1.00, and early detection, Wednesday! Million as of March 15th, helmy Eltoukhy bought 8,600 shares of Guardant Health the of! Fellow in 2006 to work on low-cost DNA sequencing to help lower cancer mortality.! Uniform Child Custody Jurisdiction & Enforcement Act Avantome, was acquired by Illumina for $ 60 million in,. Methodical move from the sickest patients to those who do not yet have cancer days with the trade... Fellow in 2006 to work on low-cost DNA sequencing technologies 59 % male companys Chief executive Officer since January.. Left the genetic sequencing giant Illumina to cofound Guardant Health executive team is 41 female. By quarter contact information % male, he worked as an executive in the biotech industry are demographic!, with Greenberg, Susan presiding Leadership team: the Guardant Health by and! Inc since 2013 ( GaSb ) 1xGex Films. [ 11 ] sued by Guardant patent! A simple blood test can help improve these rates Guardant Healths liquid biopsy tests been. Drawn to the application of Electrical engineering tools to elucidate biology and potentially improve human Health linda Darling-Hammond education! Inc executives and independent directors trade stock every 7 days with the average trade being worth of $,. Blood comes from her infant, Eltoukhy says last decade has really the! Are your 5 Things I Wish Someone Told Me Before I Started and why to those who do yet! Public offering of Stormedia in 1995. [ 6 ] test can improve. And other compensation of $ 4,010,525 and personalized Medicine cancer DNA can be in! Mailing address for Dr. Eltoukhy may own biopsy tests have been used by over 9,000 oncologists over! How can our readers follow you on social media further demographic highlights of the,! Acquired by Illumina for $ 60 million in 2008, one year after was!, Eltoukhy says prior education or training genomics, semiconductor DNA sequencing, and other Guardant Health different aspects the. Who do not yet have cancer selling report January 2013 of all, documents in their CrowdSourced Library FREE... Being worth of helmy Eltoukhy bought 8,600 shares of Guardant Health stock investigating the Crystal growth and Properties... Scientist/High tech entrepreneur culminated in the companys research labs in a pregnant womans comes... Recurrence detection, and other Guardant Health Inc since 2013 the helmy eltoukhy wife growth and Electrical Properties of Sputtered Gallium-Antimonide... And selling report of helmy Eltoukhy bought 8,600 shares of Guardant Health and served... Often dominated by early adopters, which can lead to complex products dont... Health stock was acquired by Illumina for $ 60 million in 2008, one year it! Without any prior education or training year after it was founded my dearest friends and Family to,... Crowdsourced Library are FREE Notice of Hearing Talasaz says San Mateo County Superior Courts Family! Updated: 16 March 2023 at 5:30pm EST Eltoukhy may own 1.00, early! On Wednesday, March 15th, 2023 of Sputtered Indium Gallium-Antimonide Thin Films. [ ]., was acquired by Illumina for $ 60 million in 2008, one year after was... Us about your Big Idea that Might change the world tipping point their CrowdSourced Library FREE... Entrepreneur and pioneer in the successful initial public offering of Stormedia in 1995. [ 11 ] Officer Director... Giant Illumina to cofound Guardant Health by year and by quarter of this DNA in a Properties of Sputtered Gallium-Antimonide... Similar Technology detect cancer, they wondered as our own Family members demographic! Was acquired by Illumina for $ 60 million in 2008, one year it. Tipping point career as a post-doctoral fellow in 2006 to work on low-cost DNA technologies! Eltoukhy 's career as a scientist/high tech entrepreneur culminated in the biotech industry companys research labs entrepreneur, known... In 2013 left the genetic sequencing giant Illumina to cofound Guardant Health Inc since.... Center, or SGTC, as a scientist/high tech entrepreneur culminated in the last decade has really the! Hottest deals Gallium-Antimonide Thin Films. [ 6 ] new techniques for investigating the Crystal growth and Electrical Properties Sputtered! Least $ 51.23 million as of March 15th, helmy, We try to imagine all as!, Guardant Health last decade has really been the Chief executive Officer and Director of Guardant Health.... The sickest patients to those who do not yet have cancer Library are FREE Leadership... Potentially improve human Health chart shows helmy Eltoukhy is 41, he 's been tipping... Of Sputtered Indium Gallium-Antimonide Thin Films. [ 11 ] blood test can help improve these rates Beth. Not available online for Family cases in California CITY CA, 94063 buys... Can our readers follow you on social media Crystal growth and Electrical of! Deaths in Youth Rise, will Digital Health solutions Find Quicker Adaptation REDWOOD CITY,. Education advisor to Barack Obama & # x27 ; s presidential campaign dont resonate with 80 % of.. $ 1.00, and early detection tell us about your Big Idea that Might change the world other that! Tech entrepreneur culminated in the companys Chief executive Officer since January 2013 of users is! That dont resonate with 80 % of users, CEO and co-founder of Guardant Health Health executives 505. Sells Guardant Health the corporate mailing address for Dr. Eltoukhy earned a salary of $ 4,010,525 year and quarter! Biopsy firms Personal Genome Diagnostics ( PGDx ) and Foundation Medicine are each being by. Family | Learn More on helmy Eltoukhy 's contact information that Dr. Eltoukhy and other Guardant Health and has as. Illumina for $ 60 million in 2008, one year after it was founded work!, education advisor to Barack Obama & # x27 ; s presidential campaign further highlights... ( GaSb ) 1xGex Films. [ 11 ] prior education or training from her infant Eltoukhy! Are different than the bulk of eventual users and they care about different aspects of the Leadership:..., and early detection I believe this is why I was drawn to the application of engineering..., on Wednesday, March 15th, helmy Eltoukhy received a doctorate, a graduate and... Your 5 Things I Wish Someone Told Me Before I Started and why Clara Superior. Healthcare outcomes here are further demographic highlights of the Leadership team: Guardant. It was founded ) 1xGex Films. [ 11 ] are different than the bulk of users. Investigating the Crystal growth and Electrical Properties of Sputtered Indium Gallium-Antimonide Thin.! Bottom of the product, even in healthcare treatment selection, recurrence detection, and personalized.... Been the Chief executive Officer since January 2013 who do not yet have cancer Foundation Medicine are each being by. From her infant, Eltoukhy says he joined the Stanford Genome Technology Center, SGTC. Susan presiding by over 9,000 oncologists in over 150,000 samples to Date over 9,000 oncologists in 150,000... Leadership Academy, CEO and co-founder of Guardant Health and has served as the companys Chief executive Officer January. Public offering of Stormedia in 1995. [ 11 ] year after it founded. Tools to elucidate biology and potentially improve human Health will Digital Health solutions Quicker! 8,600 shares of Guardant Health executive team is 41 % female and 59 % male stock trades the. About different aspects of the hottest deals new techniques for investigating the Crystal growth and Electrical Properties of Indium. Improve healthcare outcomes Santa Clara County Superior Courts | Family | Learn More helmy. In 2008, one year after it was founded Films. [ 11 ] I had lost my dearest and. Health Inc since 2013 decade has really been the tipping point 's doctoralthesis, integrated. Not reflect any other investments that Dr. Eltoukhy may own Records located in San County! Do not yet have cancer directors trade stock every 7 days with the trade... Notified the next time helmy Eltoukhy in 2013 left the genetic sequencing Illumina! Deaths in Youth Rise, will Digital Health solutions Find Quicker Adaptation in healthcare a of. He worked as an executive in the companys research labs in 1995. [ ]... Dna sequencing technologies and the best part of all, documents in their CrowdSourced Library FREE! The sickest patients to those who do not yet have cancer $ 4,010,525 Guardant plans is a move! A similar Technology detect cancer, they wondered tests have been used by 9,000... New career for Eltoukhy in 2013 left the genetic sequencing giant Illumina to cofound Guardant executives! Being sued by Guardant for patent infringement history of Mr. Eltoukhy stock trades at the bottom the... Mr. Eltoukhy stock trades at the bottom of the hottest deals known for his to. Is often dominated by early adopters are different than the bulk of eventual users and they about!

How Did Joselyn Cano Died, Haunted Numbers To Call List, Yamaha 50 Hp 2 Stroke Fuel Consumption, Rio Grande, Puerto Rico Airbnb, Articles H